Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Regulatory Actions
CalPERS Calls on Members of the U.S. House of Representatives to Preserve Access to Safe, Affordable Generics
April 11th, 2007
Congress needs to introduce competition into the biopharmaceutical marketplace by giving the Food and Drug Administration (FDA) authority to approve safe biogenerics, a trustee of the nation's third largest health care purchaser urged today. Priya Mathur, Vice-Chair of the California Public Employees' Retirement System (CalPERS) Health Benefits Committee, called on members of the U.S. House of Representatives to support legislation that opens the door to biogeneric competition. Testifying before the U.S. House of Representatives Committee on Government Oversight and Reform, Mathur stated that CalPERS' spending for biotech products is distressingly...
Source: Medical Patent Law Weekly (2007-04-11)
|
